Stock XTLB XTL BIOPHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases XTL Biopharmaceuticals Ltd. Nasdaq

Equities

XTLB

US98386D3070

Market Closed - Nasdaq
Other stock markets
 20:59:52 15/05/2024 BST 		5-day change 1st Jan Change
2.74 USD +6.61% Intraday chart for XTL Biopharmaceuticals Ltd. +11.84% +171.26%
04-30 XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-29 Top Premarket Gainers MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
XTL Biopharmaceuticals : Report Of Foreign Private Issuer - Form 6-K
PU
XTL Biopharmaceuticals : Immediate Report of Meeting
PU
XTL Biopharmaceuticals : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 30, 2024 - Form 6-K
PU
XTL To Aquire The Social Proxy
AQ
XTL Biopharmaceuticals : Report Of Foreign Private Issuer - Form 6-K
PU
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
AQ
XTL Biopharmaceuticals : OPERATING AND FINANCIAL REVIEW AND PROSPECTS (Form 6-K)
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XTLB Stock
  4. XTLB Stock
  5. News XTL Biopharmaceuticals Ltd.
  6. Press Releases